ArticlePharmaceutical biology2020

Latifolin protects against myocardial infarction by alleviating myocardial inflammatory via the HIF-1α/NF-κB/IL-6 pathway.

Xiao-Xiao Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.